ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Gastroenterology

Top Gastroenterology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT BEITMAN MD

Gastroenterology

14,553

$979K

546
343 are 65+

16%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$67
Average prescription price

Avg: $146

ALOK GOYAL M.D.

Gastroenterology

13,612

$737K

696
537 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 40%

$54
Average prescription price

Avg: $146

BHANWARLAL CHOWDHURY M.D.

Gastroenterology

9,427

$474K

365
321 are 65+

12%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 40%

$50
Average prescription price

Avg: $146

DAVID GRABER

Gastroenterology

6,288

$393K

302
273 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 40%

$62
Average prescription price

Avg: $146

MOIZ KARU MD

Gastroenterology

5,655

$373K

413
364 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 40%

$66
Average prescription price

Avg: $146

WARREN WERBITT DO, MD

Gastroenterology

4,610

$738K

744
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 40%

$160
Average prescription price

Avg: $146

HOWARD BAUM

Gastroenterology

4,435

$301K

369
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$68
Average prescription price

Avg: $146

MARK WAXMAN MD

Gastroenterology

4,373

$341K

244
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 40%

$78
Average prescription price

Avg: $146

SCOTT LIPPE MD

Gastroenterology

4,302

$501K

240
143 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 40%

$116
Average prescription price

Avg: $146

FRANK CANDIDO MD

Gastroenterology

4,228

$372K

246
217 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 40%

$88
Average prescription price

Avg: $146

NIKOLAOS PYRSOPOULOS MD,PHD,MBA

Gastroenterology

3,930

$1.9M

274
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 40%

$483
Average prescription price

Avg: $146

JANARDHAN BOLLU MD

Gastroenterology

3,875

$276K

565
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$71
Average prescription price

Avg: $146

THADDEUS GRABOWY MD

Gastroenterology

3,864

$266K

386
358 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 40%

$69
Average prescription price

Avg: $146

PETER CARIDE MD

Gastroenterology

3,769

$310K

978
891 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 40%

$82
Average prescription price

Avg: $146

STEVEN GILLON D.O.

Gastroenterology

3,730

$412K

258
202 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 40%

$110
Average prescription price

Avg: $146

ROBERT LINTZ MD

Gastroenterology

3,664

$369K

324
278 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$101
Average prescription price

Avg: $146

RAJAN SHAH MD

Gastroenterology

3,645

$244K

320
246 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 40%

$67
Average prescription price

Avg: $146

JOHN FARKAS MD

Gastroenterology

3,448

$281K

158
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 40%

$81
Average prescription price

Avg: $146

ZAMIR BRELVI M.D.

Gastroenterology

3,340

$1.27M

373
252 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 40%

$380
Average prescription price

Avg: $146

ANDREW STEFANIWSKY M.D.

Gastroenterology

3,269

$312K

384
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 40%

$95
Average prescription price

Avg: $146

RAMON FERNANDEZ-LEDON M.D.

Gastroenterology

3,227

$424K

478
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 40%

$131
Average prescription price

Avg: $146

PARTHIV RAVAL M.D.

Gastroenterology

3,185

$390K

440
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 40%

$123
Average prescription price

Avg: $146

ROBERT KOGAN M.D.

Gastroenterology

3,169

$272K

128
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 40%

$86
Average prescription price

Avg: $146

JEFFREY LEFKOWITZ MD

Gastroenterology

3,085

$383K

314
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 40%

$124
Average prescription price

Avg: $146

FIRPO GUERRERO M.D.

Gastroenterology

3,033

$219K

746
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 40%

$72
Average prescription price

Avg: $146

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank